# Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension

> **NCT02176499** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 26 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Telmisartan, low dose
- **DRUG:** Telmisartan, high dose
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02176499
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-02
- **Primary completion:** 1999-07
- **Final completion:** —
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02176499

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02176499, "Natriuretic Effect of Telmisartan Versus Placebo in Patients With Mild-to-Moderate Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02176499. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*